Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Contrast Enhancement in Magnetic Resonance Imaging”

114 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 114 results

Not applicableStudy completedNCT03451955
What this trial is testing

The Effect of a Gluten Free Diet on the Permeability of the Blood Brain Barrier in Patients With CIS

Who this might be right for
Optic NeuritisMultiple SclerosisClinically Isolated Syndrome
University of Copenhagen 103
Not applicableStudy completedNCT02367209
What this trial is testing

Assessment of Lung Perfusion in Patients With Chronic Obstructive Pulmonary Disease Using FD MRI

Who this might be right for
COPD
University Hospital, Basel, Switzerland 14
Testing effectiveness (Phase 2)Study completedNCT06731738
What this trial is testing

Mangafodipir - an Intracellular Contrast Agent for Magnetic Resonance Imaging (MRI): Measuring Manganese Uptake Rate in Heart Failure Patients With Preserved Ejection Fraction (HFpEF) Patients.

Who this might be right for
Heart Failure With Preserved Ejection Fraction (HFPEF)
IC TARGETS AS 44
Not applicableUnknownNCT05550090
What this trial is testing

Dynamic Contrast-enhanced MRI Combined With IVIM-DWI for Early Prediction of Chemosensitivity in Liver MBC

Who this might be right for
Metastatic Breast Cancer in the Liver
Zhejiang Cancer Hospital 40
Post-approval studies (Phase 4)Study completedNCT00908310
What this trial is testing

Post-marketing Safety Study in Patients With Moderate Renal Insufficiency Who Receive Omniscan for Contrast-enhanced Magnetic Resonance Imaging (MRI)

Who this might be right for
Chronic Kidney DiseaseRenal Insufficiency
GE Healthcare 213
Not applicableUnknownNCT00172562
What this trial is testing

Bone Marrow Angiogenesis in Acute Myeloid Leukemia - Evaluated by Dynamic Contrast Enhanced Magnetic Resonance (MR) Image

Who this might be right for
Acute Myeloid Leukemia
National Taiwan University Hospital
Not applicableUnknownNCT04181281
What this trial is testing

Validation of Renal Perfusion CEUS Against MRI, and Its Application in Acute Kidney Injury

Who this might be right for
Kidney Injury, AcutePerfusion ImagingUltrasonography+1 more
University of Nottingham 50
Not applicableUnknownNCT04626492
What this trial is testing

Quantitative MRI Imaging in Diffuse Liver Diseases

Who this might be right for
Fibrosis and Cirrhosis of Liver
Fifth Affiliated Hospital, Sun Yat-Sen University 150
Not applicableStudy completedNCT00946140
What this trial is testing

Motion Correction in Dynamic Contrast Enhanced Magnetic Resonance Imaging (MRI) in Ovarian Cancer: A Pilot Study

Who this might be right for
Ovarian Cancer
Memorial Sloan Kettering Cancer Center 2
Not applicableStudy completedNCT03455283
What this trial is testing

Post-marketing Safety Study in Participants of All Pathologies Who Receive Gadolinium-Based Contrast Agents (GBCAs) for Contrast-Enhanced Magnetic Resonance Imaging (MR) Examination

Who this might be right for
Magnetic Resonance Imaging (MRI)
GE Healthcare 2,118
Early research (Phase 1)Study completedNCT06125366
What this trial is testing

Learn More About the Safety and the Level of BAY 1747846 in Body Given as Injection Into the Vein at Increasing Single Doses in Japanese Healthy Male Participants

Who this might be right for
Contrast Enhancement in Magnetic Resonance ImagingHealthy Volunteers
Bayer 25
Large-scale testing (Phase 3)Study completedNCT01010932
What this trial is testing

Carotid and Vertebral Magnetic Resonance Angiography (MRA) Study Comparing Dotarem and Time Of Flight (TOF)

Who this might be right for
Cerebral Arterial Diseases
Guerbet 222
Large-scale testing (Phase 3)Study completedNCT00309075
What this trial is testing

Magnevist® Injection Enhanced MRA Compared to Non Contrast MRA for the Detection of Stenosis in the Calf and/or Pedal Arteries

Who this might be right for
Stenosis
Bayer 126
Not applicableActive Not RecruitingNCT01653080
What this trial is testing

MRI in Diagnosing Solid Tumors of the Eye and Orbit

Who this might be right for
Eye Cancer
University of Cincinnati 80
Early research (Phase 1)Study completedNCT00610493
What this trial is testing

Bevacizumab and Temsirolimus in Patients With Advanced Malignancy

Who this might be right for
Advanced Cancer
M.D. Anderson Cancer Center 193
Not applicableEnded earlyNCT01303419
What this trial is testing

Contrast-Enhanced Digital Mammography (CEDM) for Identifying a Change in Management of Women With Newly Diagnosed Breast Cancer

Who this might be right for
Breast Cancer
GE Healthcare 224
Large-scale testing (Phase 3)Study completedNCT05915728
What this trial is testing

Compare How Well Gadoquatrane Works and Its Safety With an Already Available Contrast Agent for MRI in People With Any Known or Suspected Problems of the Body (Except Brain or Spinal Cord-related Problems)

Who this might be right for
Contrast Enhancement in Magnetic Resonance ImagingNon-central Nervous System Pathology
Bayer 404
Not applicableUnknownNCT03097822
What this trial is testing

Response Prediction After GKS in Patients With Vestibular Schwannoma Using DCE MR Imaging

Who this might be right for
Vestibular Schwannoma
Seoul National University Hospital 90
Large-scale testing (Phase 3)Study completedNCT05915702
What this trial is testing

Compare How Well Gadoquatrane Works and Its Safety With an Already Available Contrast Agent for MRI in People With Known or Suspected Brain or Spinal Cord-related Problems

Who this might be right for
Contrast Enhancement in Magnetic Resonance ImagingCentral Nervous System Pathology
Bayer 303
Not applicableStudy completedNCT00549861
What this trial is testing

Characterization of Irreversible Myocardial Injury in Cardiomyopathies by Contrast-enhanced CMR

Who this might be right for
Cardiomyopathy, DilatedCardiomyopathies, Secondary
Oliver Strohm 40
Load More Results